Journal Title：Bioengineering

Aims

Bioengineering (ISSN 2306-5354) provides an advanced forum for the science and technology of bioengineering. It publishes original research papers, comprehensive reviews, communications and case reports. Our aim is to encourage scientists to publish their experimental and theoretical results in as much detail as possible. All aspects of bioengineering are welcomed from theoretical concepts to education and applications. There is no restriction on the length of the papers. The full experimental details must be provided so that the results can be reproduced. There are, in addition, four key features of this Journal:

● We are introducing a new concept in scientific and technical publications “The Translational Case Report in Bioengineering”. It is a descriptive explanatory analysis of a transformative or translational event. Understanding that the goal of bioengineering scholarship is to advance towards a transformative or clinical solution to an identified transformative/clinical need, the translational case report is used to explore causation in order to find underlying principles that may guide other similar transformative/translational undertakings.

● Manuscripts regarding research proposals and research ideas will be particularly welcomed.

● Electronic files and software regarding the full details of the calculation and experimental procedure, if unable to be published in a normal way, can be deposited as supplementary material.

● We also accept manuscripts communicating to a broader audience with regard to research projects financed with public funds.

Scope

● Bionics and biological cybernetics: implantology; bio–abio interfaces

● Bioelectronics: wearable electronics; implantable electronics; “more than Moore” electronics; bioelectronics devices

● Bioprocess and biosystems engineering and applications: bioprocess design; biocatalysis; bioseparation and bioreactors; bioinformatics; bioenergy; etc.

● Biomolecular, cellular and tissue engineering and applications: tissue engineering; chromosome engineering; embryo engineering; cellular, molecular and synthetic biology; metabolic engineering; bio-nanotechnology; micro/nano technologies; genetic engineering; transgenic technology

● Biomedical engineering and applications: biomechatronics; biomedical electronics; biomechanics; biomaterials; biomimetics; biomedical diagnostics; biomedical therapy; biomedical devices; sensors and circuits; biomedical imaging and medical information systems; implants and regenerative medicine; neurotechnology; clinical engineering; rehabilitation engineering

● Biochemical engineering and applications: metabolic pathway engineering; modeling and simulation

● Translational bioengineering

目標(biāo)

《生物工程》（ISSN 2306-5354）為生物工程科學(xué)和技術(shù)提供了一個(gè)高級(jí)論壇。它發(fā)表原創(chuàng)研究論文、綜合評(píng)論、通訊和案例報(bào)告。我們的目標(biāo)是鼓勵(lì)科學(xué)家盡可能詳細(xì)地發(fā)表他們的實(shí)驗(yàn)和理論結(jié)果。從理論概念到教育和應(yīng)用，生物工程的各個(gè)方面都受到歡迎。論文長度沒有限制。必須提供完整的實(shí)驗(yàn)細(xì)節(jié)，以便可以重現(xiàn)結(jié)果。此外，本期刊還有四個(gè)主要特點(diǎn)：

● 我們?cè)诳茖W(xué)和技術(shù)出版物中引入了一個(gè)新概念“生物工程中的轉(zhuǎn)化案例報(bào)告”。它是對(duì)轉(zhuǎn)化或轉(zhuǎn)化事件的描述性解釋分析。生物工程學(xué)術(shù)研究的目標(biāo)是針對(duì)已確定的轉(zhuǎn)化/臨床需求，向轉(zhuǎn)化或臨床解決方案邁進(jìn)，轉(zhuǎn)化病例報(bào)告用于探索因果關(guān)系，以找到可能指導(dǎo)其他類似轉(zhuǎn)化/轉(zhuǎn)化工作的基本原則。

● 特別歡迎有關(guān)研究提案和研究想法的手稿。

● 如果無法以正常方式發(fā)布，則可以將有關(guān)計(jì)算和實(shí)驗(yàn)過程全部細(xì)節(jié)的電子文件和軟件作為補(bǔ)充材料存放。

● 我們還接受與公共資金資助的研究項(xiàng)目相關(guān)的面向更廣泛受眾的手稿。

范圍

● 仿生學(xué)和生物控制論：種植學(xué)；生物-非生物界面

● 生物電子學(xué)：可穿戴電子學(xué)；植入式電子學(xué)；“超越摩爾”電子學(xué)；生物電子設(shè)備

● 生物過程和生物系統(tǒng)工程及應(yīng)用：生物過程設(shè)計(jì)；生物催化；生物分離與生物反應(yīng)器；生物信息學(xué)；生物能源等。

● 生物分子、細(xì)胞和組織工程及應(yīng)用：組織工程；染色體工程；胚胎工程；細(xì)胞、分子與合成生物學(xué)；代謝工程；生物納米技術(shù)；微納米技術(shù)；基因工程；轉(zhuǎn)基因技術(shù)

● 生物醫(yī)學(xué)工程及應(yīng)用：生物機(jī)電一體化；生物醫(yī)學(xué)電子學(xué)；生物力學(xué)；生物材料；仿生學(xué)；生物醫(yī)學(xué)診斷；生物醫(yī)學(xué)治療；生物醫(yī)學(xué)設(shè)備；傳感器與電路；生物醫(yī)學(xué)成像與醫(yī)學(xué)信息系統(tǒng)；植入物與再生醫(yī)學(xué)；神經(jīng)技術(shù)；臨床工程；康復(fù)工程

● 生化工程及應(yīng)用：代謝途徑工程；建模與仿真

● 轉(zhuǎn)化生物工程

Bioengineering創(chuàng)刊于2014年，由Multidisciplinary Digital Publishing Institute (MDPI)出版商出版，收稿方向涵蓋Chemical Engineering - Bioengineering全領(lǐng)域，此刊是中等級(jí)別的SCI期刊，所以過審相對(duì)來講不是特別難，但是該刊專業(yè)認(rèn)可度不錯(cuò)，仍然是一本值得選擇的SCI期刊 。平均審稿速度 first decision approximately 15.9 days after submission; acceptance to publication is undertaken in 3.7 days ，該期刊近期沒有被列入國際期刊預(yù)警名單，廣大學(xué)者值得一試。